ARCHIVES

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

This article is from The Cancer Letter archive.

Vol. 08 No. 24 | June 11, 1982

Download PDF Visit The Full Archive

Related Articles

After Congressional Inquiry, NCI Posts Ambiguous Statement On Abortion And Breast Cancer Risk

December 13, 2002

NIEHS Uses Gene Chips To Evaluate Chemicals.

March 3, 2000

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

November 23, 1979

Klausner: “The More We Know About The Causes, The Better We Are at Prevention”

June 27, 1997

Guidelines Adopted For Pathology Review

February 22, 1980

NCCS Begins Program To Help Develop Survivors’ Care Plan

February 27, 2009